Literature DB >> 28124109

Decompression endoscopic surgery for frontal secondary headache attributed to supraorbital and supratrochlear nerve entrapment: a comprehensive review.

Boris Filipović1,2,3, J Alexander de Ru4, Rick van de Langenberg5, Pepijn A Borggreven5, Zdravko Lacković6, Peter J F M Lohuis5.   

Abstract

In the last decade, a new surgical treatment modality was developed for frontal secondary headache, based on the assumption that the trigger of this pain entity is the entrapment of peripheral sensory nerves. The surgery entails a procedure, where an endoscopic approach is used to decompress the supraorbital and supratrochlear nerve branches, which are entrapped by the periosteum in the region of the corrugator supercilii muscle. Candidates for the surgery define their headache as moderate to severe persistent daily pressure or tension, localized in the frontal area, sometimes accompanied by symptoms of nausea and photophobia mimicking a primary headache-migraine. We created a step-by-step screening algorithm which is used to differentiate patients that have the highest chance for a successful surgical decompression. Up to now, published data regarding this type of surgery demonstrate long-lasting successful outcomes while adverse effects are minor. This article reviews and discusses from a surgeon's perspective decompression surgery for secondary headache attributed to supraorbital and supratrochlear nerve entrapment.

Entities:  

Keywords:  Botulinum toxin type A; Decompression endoscopic surgery; Migraine; Migraine surgery; Nerve entrapment; Secondary headache

Mesh:

Year:  2017        PMID: 28124109     DOI: 10.1007/s00405-017-4450-x

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  44 in total

1.  The Use of Botulinum Toxin in the Management of Headache Disorders.

Authors:  Stephen D Silberstein
Journal:  Semin Neurol       Date:  2016-02-11       Impact factor: 3.420

2.  Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study.

Authors:  Lesley Wood; Matthias Egger; Lise Lotte Gluud; Kenneth F Schulz; Peter Jüni; Douglas G Altman; Christian Gluud; Richard M Martin; Anthony J G Wood; Jonathan A C Sterne
Journal:  BMJ       Date:  2008-03-03

3.  Corrugator superciliaris muscle excision for tension and migraine headaches.

Authors:  William H Bearden; Richard L Anderson
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2005-11       Impact factor: 1.746

4.  Factors contributing to migraine headache surgery failure and success.

Authors:  Kelsey Larson; Michelle Lee; Janine Davis; Bahman Guyuron
Journal:  Plast Reconstr Surg       Date:  2011-11       Impact factor: 4.730

5.  Positive botulinum toxin type a response is a prognosticator for migraine surgery success.

Authors:  Michelle Lee; Mikhal A Monson; Mengyuan T Liu; Deborah Reed; Bahman Guyuron
Journal:  Plast Reconstr Surg       Date:  2013-04       Impact factor: 4.730

6.  Clinical outcomes following supraorbital foraminotomy for treatment of frontal migraine headache.

Authors:  Kyle J Chepla; Eugene Oh; Bahman Guyuron
Journal:  Plast Reconstr Surg       Date:  2012-04       Impact factor: 4.730

7.  Corrugator supercilii muscle resection and migraine headaches.

Authors:  B Guyuron; A Varghai; B J Michelow; T Thomas; J Davis
Journal:  Plast Reconstr Surg       Date:  2000-08       Impact factor: 4.730

8.  Dural neurogenic inflammation induced by neuropathic pain is specific to cranial region.

Authors:  B Filipović; I Matak; Z Lacković
Journal:  J Neural Transm (Vienna)       Date:  2013-12-24       Impact factor: 3.575

Review 9.  Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine.

Authors:  David Dodick; Richard B Lipton; Vincent Martin; Vasilios Papademetriou; Wayne Rosamond; Antoinette MaassenVanDenBrink; Hassan Loutfi; K Michael Welch; Peter J Goadsby; Steven Hahn; Susan Hutchinson; David Matchar; Stephen Silberstein; Timothy R Smith; R Allan Purdy; Jane Saiers
Journal:  Headache       Date:  2004-05       Impact factor: 5.887

10.  Nonendoscopic deactivation of nerve triggers in migraine headache patients: surgical technique and outcomes.

Authors:  Lisa Gfrerer; Daniel Y Maman; Oren Tessler; William G Austen
Journal:  Plast Reconstr Surg       Date:  2014-10       Impact factor: 4.730

View more
  1 in total

1.  Treatment of Frontal Secondary Headache Attributed to Supratrochlear and Supraorbital Nerve Entrapment With Oral Medication or Botulinum Toxin Type A vs Endoscopic Decompression Surgery.

Authors:  Boris Filipovic; J Alexander de Ru; Sara Hakim; Rick van de Langenberg; Pepijn A Borggreven; Peter J F M Lohuis
Journal:  JAMA Facial Plast Surg       Date:  2018-09-01       Impact factor: 4.611

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.